Winter 2017

This edition of RxInformer examines drug trends, population characteristics, and policy initiatives impacting management of injured workers.


get the e-book
article thumbnail image
Policy

State of States

State of States

article thumbnail image
Trends & Stats

By the Numbers

A collection of workers' compensation facts and figures

article thumbnail image
Pain Management

New Pathways in Pain Management: Novel Non-Opioid Medications

Current research explores non-opioid neuropathways for pain management

article thumbnail image
Medication Management

Infographic: Medication Multiplication

How opioid side effects can cascade across the body

article thumbnail image
Medication Management

Patient Age: More than a Number in Rx Management

Age, as well as overall health, must be considered in medication management

article thumbnail image
Policy

Reality Check: New FDA Initiatives Re-Examine Opioid Policies

The FDA acknowledges the need to shift opioid policies as overdose rates continue to rise

article thumbnail image
Medication Management

6 Specialty Drug Trends Impacting Workers' Comp Right Now

Health and cost impacts of specialty drugs for chronic conditions seen in workers' comp

article thumbnail image
Medication Management

Claims Q&A: RX Drugs of Abuse: Which Non-Opioid Drugs Present Concern?

Our clinicians answer common questions from claims professionals

article thumbnail image
ABM

Perspectives: Use of Virtual Reality and Video Games in Physical Therapy

Industry thought leaders share their insights

Be the first to know when a new issue of Rxinformer is released

Sign up for e-mail alerts now!

RxInformer

Since 2010, the semi-annual RxInformer clinical journal has been a trusted source of timely information and guidance for workers’ comp payers on how best to manage the care of injured worker claimants and plan for the challenges that lay ahead. The publication is an important part of Healthesystems’ proactive approach to advocating for quality care of injured workers while managing the costs associated with treatment.
cross